Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600128955) titled 'The application of a novel aldosterone synthase CYP11B2 targeted PET/CT imaging' on July 28.
Study Type: Diagnostic test
Study Design:
Diagnostic test for accuracy
Primary Sponsor: Ganzhou People's Hospital
Condition:
Patients diagnosed with primary aldosteronism, or those clinically highly suspected of having primary aldosteronism who need further lesion localization and subtype classification.
Intervention:
Gold Standard:The diagnosis of PA relies on the screening of plasma aldosterone/renin ratio (ARR) and subsequent confirmatory tests, while the classification mainly depends on adrenal venous sampling (...